Cargando…

Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial

BACKGROUND: Standard treatment of Duchenne muscular dystrophy (DMD) includes regular physiotherapy. There are no data to show whether adding aquatic therapy (AT) to land-based exercises helps maintain motor function. We assessed the feasibility of recruiting and collecting data from boys with DMD in...

Descripción completa

Detalles Bibliográficos
Autores principales: Hind, Daniel, Parkin, James, Whitworth, Victoria, Rex, Saleema, Young, Tracey, Hampson, Lisa, Sheehan, Jennie, Maguire, Chin, Cantrill, Hannah, Scott, Elaine, Epps, Heather, Main, Marion, Geary, Michelle, McMurchie, Heather, Pallant, Lindsey, Woods, Daniel, Freeman, Jennifer, Lee, Ellen, Eagle, Michelle, Willis, Tracey, Muntoni, Francesco, Baxter, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367005/
https://www.ncbi.nlm.nih.gov/pubmed/28357131
http://dx.doi.org/10.1186/s40814-017-0132-0
_version_ 1782517695229460480
author Hind, Daniel
Parkin, James
Whitworth, Victoria
Rex, Saleema
Young, Tracey
Hampson, Lisa
Sheehan, Jennie
Maguire, Chin
Cantrill, Hannah
Scott, Elaine
Epps, Heather
Main, Marion
Geary, Michelle
McMurchie, Heather
Pallant, Lindsey
Woods, Daniel
Freeman, Jennifer
Lee, Ellen
Eagle, Michelle
Willis, Tracey
Muntoni, Francesco
Baxter, Peter
author_facet Hind, Daniel
Parkin, James
Whitworth, Victoria
Rex, Saleema
Young, Tracey
Hampson, Lisa
Sheehan, Jennie
Maguire, Chin
Cantrill, Hannah
Scott, Elaine
Epps, Heather
Main, Marion
Geary, Michelle
McMurchie, Heather
Pallant, Lindsey
Woods, Daniel
Freeman, Jennifer
Lee, Ellen
Eagle, Michelle
Willis, Tracey
Muntoni, Francesco
Baxter, Peter
author_sort Hind, Daniel
collection PubMed
description BACKGROUND: Standard treatment of Duchenne muscular dystrophy (DMD) includes regular physiotherapy. There are no data to show whether adding aquatic therapy (AT) to land-based exercises helps maintain motor function. We assessed the feasibility of recruiting and collecting data from boys with DMD in a parallel-group pilot randomised trial (primary objective), also assessing how intervention and trial procedures work. METHODS: Ambulant boys with DMD aged 7–16 years established on steroids, with North Star Ambulatory Assessment (NSAA) score ≥8, who were able to complete a 10-m walk test without aids or assistance, were randomly allocated (1:1) to 6 months of either optimised land-based exercises 4 to 6 days/week, defined by local community physiotherapists, or the same 4 days/week plus AT 2 days/week. Those unable to commit to a programme, with >20% variation between NSAA scores 4 weeks apart, or contraindications to AT were excluded. The main outcome measures included feasibility of recruiting 40 participants in 6 months from six UK centres, clinical outcomes including NSAA, independent assessment of treatment optimisation, participant/therapist views on acceptability of intervention and research protocols, value of information (VoI) analysis and cost-impact analysis. RESULTS: Over 6 months, 348 boys were screened: most lived too far from centres or were enrolled in other trials; 12 (30% of the targets) were randomised to AT (n = 8) or control (n = 4). The mean change in NSAA at 6 months was −5.5 (SD 7.8) in the control arm and −2.8 (SD 4.1) in the AT arm. Harms included fatigue in two boys, pain in one. Physiotherapists and parents valued AT but believed it should be delivered in community settings. Randomisation was unattractive to families, who had already decided that AT was useful and who often preferred to enrol in drug studies. The AT prescription was considered to be optimised for three boys, with other boys given programmes that were too extensive and insufficiently focused. Recruitment was insufficient for VoI analysis. CONCLUSIONS: Neither a UK-based RCT of AT nor a twice weekly AT therapy delivered at tertiary centres is feasible. Our study will help in the optimisation of AT service provision and the design of future research. TRIAL REGISTRATION: ISRCTN41002956 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40814-017-0132-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5367005
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53670052017-03-29 Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial Hind, Daniel Parkin, James Whitworth, Victoria Rex, Saleema Young, Tracey Hampson, Lisa Sheehan, Jennie Maguire, Chin Cantrill, Hannah Scott, Elaine Epps, Heather Main, Marion Geary, Michelle McMurchie, Heather Pallant, Lindsey Woods, Daniel Freeman, Jennifer Lee, Ellen Eagle, Michelle Willis, Tracey Muntoni, Francesco Baxter, Peter Pilot Feasibility Stud Research BACKGROUND: Standard treatment of Duchenne muscular dystrophy (DMD) includes regular physiotherapy. There are no data to show whether adding aquatic therapy (AT) to land-based exercises helps maintain motor function. We assessed the feasibility of recruiting and collecting data from boys with DMD in a parallel-group pilot randomised trial (primary objective), also assessing how intervention and trial procedures work. METHODS: Ambulant boys with DMD aged 7–16 years established on steroids, with North Star Ambulatory Assessment (NSAA) score ≥8, who were able to complete a 10-m walk test without aids or assistance, were randomly allocated (1:1) to 6 months of either optimised land-based exercises 4 to 6 days/week, defined by local community physiotherapists, or the same 4 days/week plus AT 2 days/week. Those unable to commit to a programme, with >20% variation between NSAA scores 4 weeks apart, or contraindications to AT were excluded. The main outcome measures included feasibility of recruiting 40 participants in 6 months from six UK centres, clinical outcomes including NSAA, independent assessment of treatment optimisation, participant/therapist views on acceptability of intervention and research protocols, value of information (VoI) analysis and cost-impact analysis. RESULTS: Over 6 months, 348 boys were screened: most lived too far from centres or were enrolled in other trials; 12 (30% of the targets) were randomised to AT (n = 8) or control (n = 4). The mean change in NSAA at 6 months was −5.5 (SD 7.8) in the control arm and −2.8 (SD 4.1) in the AT arm. Harms included fatigue in two boys, pain in one. Physiotherapists and parents valued AT but believed it should be delivered in community settings. Randomisation was unattractive to families, who had already decided that AT was useful and who often preferred to enrol in drug studies. The AT prescription was considered to be optimised for three boys, with other boys given programmes that were too extensive and insufficiently focused. Recruitment was insufficient for VoI analysis. CONCLUSIONS: Neither a UK-based RCT of AT nor a twice weekly AT therapy delivered at tertiary centres is feasible. Our study will help in the optimisation of AT service provision and the design of future research. TRIAL REGISTRATION: ISRCTN41002956 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40814-017-0132-0) contains supplementary material, which is available to authorized users. BioMed Central 2017-03-27 /pmc/articles/PMC5367005/ /pubmed/28357131 http://dx.doi.org/10.1186/s40814-017-0132-0 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Hind, Daniel
Parkin, James
Whitworth, Victoria
Rex, Saleema
Young, Tracey
Hampson, Lisa
Sheehan, Jennie
Maguire, Chin
Cantrill, Hannah
Scott, Elaine
Epps, Heather
Main, Marion
Geary, Michelle
McMurchie, Heather
Pallant, Lindsey
Woods, Daniel
Freeman, Jennifer
Lee, Ellen
Eagle, Michelle
Willis, Tracey
Muntoni, Francesco
Baxter, Peter
Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial
title Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial
title_full Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial
title_fullStr Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial
title_full_unstemmed Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial
title_short Aquatic therapy for boys with Duchenne muscular dystrophy (DMD): an external pilot randomised controlled trial
title_sort aquatic therapy for boys with duchenne muscular dystrophy (dmd): an external pilot randomised controlled trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367005/
https://www.ncbi.nlm.nih.gov/pubmed/28357131
http://dx.doi.org/10.1186/s40814-017-0132-0
work_keys_str_mv AT hinddaniel aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial
AT parkinjames aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial
AT whitworthvictoria aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial
AT rexsaleema aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial
AT youngtracey aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial
AT hampsonlisa aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial
AT sheehanjennie aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial
AT maguirechin aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial
AT cantrillhannah aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial
AT scottelaine aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial
AT eppsheather aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial
AT mainmarion aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial
AT gearymichelle aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial
AT mcmurchieheather aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial
AT pallantlindsey aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial
AT woodsdaniel aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial
AT freemanjennifer aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial
AT leeellen aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial
AT eaglemichelle aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial
AT willistracey aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial
AT muntonifrancesco aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial
AT baxterpeter aquatictherapyforboyswithduchennemusculardystrophydmdanexternalpilotrandomisedcontrolledtrial